Beam Therapeutics Inc (BEAM)

07:03 AM

Beam Therapeutics Insider Sells $146K in Shares - nationaltoday.com

07:03 AM

06:17 AM

Beam Therapeutics CEO Evans sells $739k in stock By Investing.com - za.investing.com

06:17 AM

06:16 AM

Beam Therapeutics (NASDAQ:BEAM) Insider Amy Simon Sells 6,700 Shares of Stock - MarketBeat

06:16 AM

06:15 AM

John Evans Sells 30,078 Shares of Beam Therapeutics (NASDAQ:BEAM) Stock - MarketBeat

06:15 AM

06:15 AM

Beam Therapeutics (NASDAQ:BEAM) Insider Christine Bellon Sells 5,956 Shares - MarketBeat

06:15 AM

05:56 AM

Amy Simon, Beam Therapeutics CMO, sells $164,686 in stock - Investing.com

05:56 AM

05:48 AM

[Form 4] Beam Therapeutics Inc. Insider Trading Activity - Stock Titan

05:48 AM

05:47 AM

Bethany Cavanagh (Beam Therapeutics) sells $79,688 in BEAM stock - Investing.com

05:47 AM

05:46 AM

Beam Therapeutics president sells $290k in shares - Investing.com

05:46 AM

05:44 AM

Beam Therapeutics (BEAM) CMO covers tax obligations via 6,700-share sale - Stock Titan

05:44 AM

05:39 AM

Beam Therapeutics (BEAM) SVP auto-sells shares to cover RSU tax obligations - Stock Titan

05:39 AM

05:39 AM

Beam Therapeutics (BEAM) CLO auto-sells 5,956 shares for RSU tax withholding - Stock Titan

05:39 AM

05:34 AM

Beam Therapeutics (BEAM) president’s 11,810-share sale covers RSU taxes - Stock Titan

05:34 AM

Apr 05, 2026

BEAM SEC FilingsBeam Therapeutics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 05, 2026

Apr 04, 2026

Beam Therapeutics Inc. (BEAM) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 04, 2026

Apr 04, 2026

SG Americas Securities LLC Boosts Beam Therapeutics Stake by 139% - National Today

Apr 04, 2026

Apr 04, 2026

SG Americas Securities LLC Acquires 60,249 Shares of Beam Therapeutics Inc. $BEAM - MarketBeat

Apr 04, 2026

Apr 03, 2026

Beam Therapeutics Inc. (BEAM) stock price, news, quote and history - Yahoo Finance Australia

Apr 03, 2026

Apr 03, 2026

Intellia Therapeutics, Inc. (NTLA) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 03, 2026

Apr 03, 2026

Beam Therapeutics Inc. (BEAM) interactive stock chart - sg.finance.yahoo.com

Apr 03, 2026

Apr 02, 2026

Beam Therapeutics (NASDAQ: BEAM) awards 20,000 RSUs to Chief Legal Officer - Stock Titan

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM) awards 20,000 RSUs to SVP Bethany Cavanagh - Stock Titan

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM) awards 31,750 RSUs to Chief Medical Officer Amy Simon - Stock Titan

Apr 02, 2026

Apr 02, 2026

CFO of Beam Therapeutics (NASDAQ: BEAM) awarded 31,750 RSUs - Stock Titan

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM) grants president 40,000 restricted stock units - Stock Titan

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM): Among the stocks that could 10x over the next 5 years - MSN

Apr 02, 2026

Apr 02, 2026

Insider Selling: Beam Therapeutics (NASDAQ:BEAM) CEO Sells 25,000 Shares of Stock - MarketBeat

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM): Among the Stocks That Could 10x Over the Next 5 Years - Yahoo Finance

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics Insider Sold Shares Worth $1,128,315, According to a Recent SEC Filing - Moomoo

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics shares climb after positive BEAM-302 trial update - MSN

Apr 02, 2026

Apr 02, 2026

BEAM.O Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026

Apr 02, 2026

Beam (BEAM) Reports Promising Data from BEACON Trial in Sickle C - GuruFocus

Apr 02, 2026

Apr 01, 2026

Beam Therapeutics publishes sickle cell therapy trial data By Investing.com - Investing.com Australia

Apr 01, 2026

Apr 01, 2026

Why Is BEAM Stock Edging Higher After Hours Today? - Stocktwits

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics CEO Evans sells $1.1m in stock By Investing.com - in.investing.com

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics CEO Evans sells $1.1m in stock - Investing.com

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics (BEAM) CEO sells 50K shares, gains 90K RSUs - Stock Titan

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine - The Manila Times

Apr 01, 2026

Apr 01, 2026

In 31 sickle cell patients, Beam saw no severe pain crises after risto-cel - Stock Titan

Apr 01, 2026

Mar 31, 2026

[144] Beam Therapeutics Inc. SEC Filing - Stock Titan

Mar 31, 2026

Mar 31, 2026

ETRADE Financial (NASDAQ: BEAM) insider sales and restricted vesting - Stock Titan

Mar 31, 2026

Mar 31, 2026

BEAM (NASDAQ: BEAM) affiliate notifies sale of 25,000 shares via option exercise - Stock Titan

Mar 31, 2026

Mar 31, 2026

Beam to advance gene-editing drug to pivotal development - MSN

Mar 31, 2026

Mar 30, 2026

BEAM (NASDAQ: BEAM) insider schedules 25,000-share sale after option exercise - Stock Titan

Mar 30, 2026

Mar 29, 2026

Beam Therapeutics gains on clinical update as gene therapy hits protective protein levels - MSN

Mar 29, 2026

Mar 28, 2026

(BEAM) Risk Channels and Responsive Allocation - Stock Traders Daily

Mar 28, 2026

Mar 28, 2026

JPMorgan Chase & Co. Has $13.14 Million Stock Position in Beam Therapeutics Inc. $BEAM - marketbeat.com

Mar 28, 2026

Mar 28, 2026

Risk Recap: Is Beam Therapeutics Inc a cyclical or defensive stock2026 Levels & Long-Term Growth Plans - baoquankhu1.vn

Mar 28, 2026

Mar 27, 2026

BEAM Stock's Gains Fade Despite Promising Data Rare Liver Disease Treatment Data - Stocktwits

Mar 27, 2026

Mar 27, 2026

Beam Therapeutics Inc. (BEAM) Discusses Topline Phase I/II Data for BEAM-302 in Alpha-1 Antitrypsin DeficiencySlideshow (NASDAQ:BEAM) 2026-03-27 - Seeking Alpha

Mar 27, 2026

Mar 27, 2026

Beam Therapeutics (NASDAQ:BEAM) Price Targets Rise As Nasdaq Futures Move - Kalkine Media

Mar 27, 2026

Mar 27, 2026

How The Investment Story For Beam Therapeutics (BEAM) Is Quietly Shifting With New Data And Funding - Yahoo Finance

Mar 27, 2026

Mar 27, 2026

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), KalVista Pharmaceuticals (KALV) and Ionis Pharmaceuticals (IONS) - The Globe and Mail

Mar 27, 2026

Mar 27, 2026

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), Maze Therapeutics, Inc. (MAZE) and Daiichi Sankyo Company (OtherDSKYF) - The Globe and Mail

Mar 27, 2026